Susquehanna International Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $155K | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $52.4K | Sell |
|
|||||
|
2022
Q4 | $155K | Buy |
|
|||||
|
2022
Q3 | $66K | Sell |
|
|||||
|
2022
Q2 | $220K | Buy |
|
|||||
|
2022
Q1 | $31K | Sell |
|
|||||
|
2021
Q4 | $541K | Sell |
|
|||||
|
2021
Q3 | $953K | Buy |
|
|||||
|
2021
Q2 | $798K | Buy |
|
|||||
|
2021
Q1 | $676K | Sell |
|
|||||
|
2020
Q4 | $1.06M | Buy |
|
|||||
|
2020
Q3 | $629K | Buy |
|
|||||
|
2020
Q2 | $242K | Sell |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $125K | Buy |
|
|||||
|
2019
Q3 | $164K | Buy |
|
|||||
|
2019
Q2 | $133K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $147K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|